This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Why Should You Add WellCare Health (WCG) to Your Portfolio?
by Zacks Equity Research
Riding high on a solid revenue base and inorganic growth profile, WellCare Health (WCG) holds high potential to reap benefits for investors.
Why Adding HCA Healthcare to Your Portfolio Makes Sense
by Zacks Equity Research
Riding high on rising revenues and inorganic growth story, HCA Healthcare (HCA) looks promising enough to garner benefits for investors.
The Zacks Analyst Blog Highlights: SB One, Camden National, Middlesex Water, Joint and NexPoint Residential Trust
by Zacks Equity Research
The Zacks Analyst Blog Highlights: SB One, Camden National, Middlesex Water, Joint and NexPoint Residential Trust
Why You Should Hold Humana (HUM) Stock in Your Portfolio
by Zacks Equity Research
Humana (HUM) rides high on solid Medicare business growth and its strategic efforts. The stock holds immense potential to reap solid benefits for investors.
5 Top US-Focused Stocks to Buy as Trade Negotiations Stall
by Nalak Das
Trade-sensitive stocks, especially the ones that have large exposure to China or other international markets, lost a good chunk of value.
The Joint Corp. (JYNT) Is Up 9.28% in One Week: What You Should Know
by Zacks Equity Research
Does The Joint Corp. (JYNT) have what it takes to be a top stock pick for momentum investors? Let's find out.
MOH vs. JYNT: Which Stock Is the Better Value Option?
by Zacks Equity Research
MOH vs. JYNT: Which Stock Is the Better Value Option?
The Joint Corp. (JYNT) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
The Joint Corp. (JYNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MOH vs. JYNT: Which Stock Is the Better Value Option?
by Zacks Equity Research
MOH vs. JYNT: Which Stock Is the Better Value Option?
MOH vs. JYNT: Which Stock Is the Better Value Option?
by Zacks Equity Research
MOH vs. JYNT: Which Stock Is the Better Value Option?
MOH vs. JYNT: Which Stock Is the Better Value Option?
by Zacks Equity Research
MOH vs. JYNT: Which Stock Is the Better Value Option?
MOH or JYNT: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
MOH vs. JYNT: Which Stock Is the Better Value Option?
MOH or JYNT: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
MOH vs. JYNT: Which Stock Is the Better Value Option?
MOH vs. JYNT: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
MOH vs. JYNT: Which Stock Is the Better Value Option?
Zacks.com featured highlights include: TheStreet, Joint, Harvard Bioscience and CPI
by Zacks Equity Research
Zacks.com featured highlights include: TheStreet, Joint, Harvard Bioscience and CPI
4 Breakout Stocks Offering Phenomenal Returns
by Swarup Gupta
If properly implemented, such a strategy has the ability to deliver impressive returns.
Will Joint Corp (JYNT) Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in The Joint Corp. (JYNT).
The Zacks Analyst Blog Highlights: Anthem, Humana, Centene, Molina Healthcare and Joint
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Anthem, Humana, Centene, Molina Healthcare and Joint
Wellcare Health Boosts Healthcare With New Partnerships
by Zacks Equity Research
Wellcare Health (WCG) has been forming strategic alliances in order to improve its healthcare offerings across the nation.
UnitedHealth on A.M.Best's Radar After Buyout Announcement
by Zacks Equity Research
A.M.Best acknowledges UnitedHealth's(UNH) deleveraging strategy and earnings accretion from DaVita Medical Group acquisition.
Community Health (CYH) to Divest 120-Bed Hospital in Florida
by Zacks Equity Research
Community Health (CYH) has been divesting hospitals to lower its debt burden. However, these divestitures have adversely affected the company's top line.
Humana Partners Einstein Healthcare for Value-Based Care
by Zacks Equity Research
Humana (HUM) has been joining forces with other medical sector companies in order to strengthen its presence in value-based healthcare.
Zacks.com featured highlights: Akari Therapeutics, Joint, Tailored Brands, Ardelyx and BioTime
by Zacks Equity Research
Zacks.com featured highlights: Akari Therapeutics, Joint, Tailored Brands, Ardelyx and BioTime
Why It's Wise to Add WellCare (WCG) to Your Portfolio
by Zacks Equity Research
WellCare (WCC) looks a solid bet, driven by its intrinsic potency and favorable earnings growth estimates.
5 Affordable Breakout Stocks Offering Excellent Returns
by Swarup Gupta
If properly implemented, such a strategy has the ability to deliver impressive returns.